Therapeutics of Neurotransmitters in Alzheimer's Disease

Ramesh Kandimalla, P (Hemachandra) Reddy

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease, characterized by the loss of memory, multiple cognitive impairments and changes in the personality and behavior. Several decades of intense research have revealed that multiple cellular changes are involved in disease process, including synaptic damage, mitochondrial abnormalities and inflammatory responses, in addition to formation and accumulation of amyloid-β (Aβ) and phosphorylated tau. Although tremendous progress has been made in understanding the impact of neurotransmitters in the progression and pathogenesis of AD, we still do not have a drug molecule associated with neurotransmitter(s) that can delay disease process in elderly individuals and/or restore cognitive functions in AD patients. The purpose of our article is to assess the latest developments in neurotransmitters research using cell and mouse models of AD. We also updated the current status of clinical trials using neurotransmitters' agonists/antagonists in AD.

Original languageEnglish (US)
Pages (from-to)1049-1069
Number of pages21
JournalJournal of Alzheimer's Disease
Volume57
Issue number4
DOIs
StatePublished - 2017
Externally publishedYes

Fingerprint

Neurotransmitter Agents
Alzheimer Disease
Therapeutics
Memory Disorders
Research
Amyloid
Neurodegenerative Diseases
Cognition
Personality
Clinical Trials
Pharmaceutical Preparations

Keywords

  • Acetylcholine inhibitors
  • adenosine receptors
  • Alzheimer's disease
  • histaminergic
  • N-methyl-D-aspartate
  • neurotransmitters

ASJC Scopus subject areas

  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Therapeutics of Neurotransmitters in Alzheimer's Disease. / Kandimalla, Ramesh; Reddy, P (Hemachandra).

In: Journal of Alzheimer's Disease, Vol. 57, No. 4, 2017, p. 1049-1069.

Research output: Contribution to journalReview article

Kandimalla, Ramesh ; Reddy, P (Hemachandra). / Therapeutics of Neurotransmitters in Alzheimer's Disease. In: Journal of Alzheimer's Disease. 2017 ; Vol. 57, No. 4. pp. 1049-1069.
@article{df8174eb0afe4118922cb7b6702a5808,
title = "Therapeutics of Neurotransmitters in Alzheimer's Disease",
abstract = "Alzheimer's disease (AD) is a progressive neurodegenerative disease, characterized by the loss of memory, multiple cognitive impairments and changes in the personality and behavior. Several decades of intense research have revealed that multiple cellular changes are involved in disease process, including synaptic damage, mitochondrial abnormalities and inflammatory responses, in addition to formation and accumulation of amyloid-β (Aβ) and phosphorylated tau. Although tremendous progress has been made in understanding the impact of neurotransmitters in the progression and pathogenesis of AD, we still do not have a drug molecule associated with neurotransmitter(s) that can delay disease process in elderly individuals and/or restore cognitive functions in AD patients. The purpose of our article is to assess the latest developments in neurotransmitters research using cell and mouse models of AD. We also updated the current status of clinical trials using neurotransmitters' agonists/antagonists in AD.",
keywords = "Acetylcholine inhibitors, adenosine receptors, Alzheimer's disease, histaminergic, N-methyl-D-aspartate, neurotransmitters",
author = "Ramesh Kandimalla and Reddy, {P (Hemachandra)}",
year = "2017",
doi = "10.3233/JAD-161118",
language = "English (US)",
volume = "57",
pages = "1049--1069",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "4",

}

TY - JOUR

T1 - Therapeutics of Neurotransmitters in Alzheimer's Disease

AU - Kandimalla, Ramesh

AU - Reddy, P (Hemachandra)

PY - 2017

Y1 - 2017

N2 - Alzheimer's disease (AD) is a progressive neurodegenerative disease, characterized by the loss of memory, multiple cognitive impairments and changes in the personality and behavior. Several decades of intense research have revealed that multiple cellular changes are involved in disease process, including synaptic damage, mitochondrial abnormalities and inflammatory responses, in addition to formation and accumulation of amyloid-β (Aβ) and phosphorylated tau. Although tremendous progress has been made in understanding the impact of neurotransmitters in the progression and pathogenesis of AD, we still do not have a drug molecule associated with neurotransmitter(s) that can delay disease process in elderly individuals and/or restore cognitive functions in AD patients. The purpose of our article is to assess the latest developments in neurotransmitters research using cell and mouse models of AD. We also updated the current status of clinical trials using neurotransmitters' agonists/antagonists in AD.

AB - Alzheimer's disease (AD) is a progressive neurodegenerative disease, characterized by the loss of memory, multiple cognitive impairments and changes in the personality and behavior. Several decades of intense research have revealed that multiple cellular changes are involved in disease process, including synaptic damage, mitochondrial abnormalities and inflammatory responses, in addition to formation and accumulation of amyloid-β (Aβ) and phosphorylated tau. Although tremendous progress has been made in understanding the impact of neurotransmitters in the progression and pathogenesis of AD, we still do not have a drug molecule associated with neurotransmitter(s) that can delay disease process in elderly individuals and/or restore cognitive functions in AD patients. The purpose of our article is to assess the latest developments in neurotransmitters research using cell and mouse models of AD. We also updated the current status of clinical trials using neurotransmitters' agonists/antagonists in AD.

KW - Acetylcholine inhibitors

KW - adenosine receptors

KW - Alzheimer's disease

KW - histaminergic

KW - N-methyl-D-aspartate

KW - neurotransmitters

UR - http://www.scopus.com/inward/record.url?scp=85018754959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018754959&partnerID=8YFLogxK

U2 - 10.3233/JAD-161118

DO - 10.3233/JAD-161118

M3 - Review article

VL - 57

SP - 1049

EP - 1069

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 4

ER -